Global /South Korea /Healthcare /Drug Manufacturers - General /054670

Daehan Nupharm Co.,Ltd.

054670

• KRX: 054670 • Delayed

7,120KRW 0.1%

4.67 USD

As of 13 June 2026, Daehan Nupharm Co.,Ltd. has a market cap of $65.71M USD, ranking #28569 globally and #1528 in South Korea. It ranks #2587 in the Healthcare sector, and #921 in the Drug Manufacturers - General industry.

Global Rank

28569

Country Rank

1528

Sector Rank

2587

Industry Rank

921

Key Stats

Market Cap

$65.71MUSD

99.93B KRW

Enterprise Value

$108.69MUSD

165.88B KRW

Revenue (TTM)

$133.09MUSD

202.4B KRW

EBITDA (TTM)

$10.5MUSD

16.03B KRW

Net Income (TTM)

$10.03MUSD

15.26B KRW

EBITDA Margin

7.9%

Profit Margin

7.5%

PE Ratio

6.5

PS Ratio

0.5

PB Ratio

0.7

EV/EBITDA

10.5

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Wonseok Lee open_in_new

Employees

228

Founded

1984

Website

dhnp.co.kr open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0.1%	-0.7%	-1.9%	7.7%	4.9%	8.4%	2.4%	-18%	-40%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	054670 대한뉴팜(주) ISIN: KR7054670005 Shares Out.: Shares Outstanding: 14.035M¹ Shares Float: 7.99M² TV: TradingView: KRX: 054670 SA: Stock Analysis: KRX: 054670 YF: Yahoo Finance: 054670.KS GF: Google Finance: KRX: 054670 BA: Barron's: 054670 MS: Morningstar: XKRX: 054670	7,120 KRW	TV: TradingView: KRX: 054670 SA: Stock Analysis: KRX: 054670 YF: Yahoo Finance: 054670.KS GF: Google Finance: KRX: 054670 BA: Barron's: 054670 MS: Morningstar: XKRX: 054670

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Daehan Nupharm Co.,Ltd.

Daehan Nupharm Co.,Ltd. manufactures and sells pharmaceuticals and veterinary products in South Korea and internationally. It offers pharmaceuticals drugs for cardiovascular, endocrine system, neuropsychiatric, gastrointestinal, respiratory system, antipyretic, analgesic, anti-inflammatory, anti-infective, musculoskeletal, osteoporosis, anti-cancer, urogenital system, antifungal, antiviral, hormones, dermatologic, central nervous system, anticonvulsive, amino acid, anesthetic, antiobesity, and others; vitamins; and inorganic products. The company also provides animal health and nutrition products; health supplements; and aesthetic/medical devices. The company was formerly known as Daehan New Pharm Co., Ltd and changed its name to Daehan Nupharm Co.,Ltd. in March 2025. Daehan Nupharm Co.,Ltd. was founded in 1984 and is headquartered in Hwaseong-si, South Korea.

Similar Companies

Industry: Drug Manufacturers - General (South Korea)

Name	Market Cap (USD) diff.	PE	Country
Samsung Epis Holdings Co., Ltd. KRX: 0126Z0	$9.15B 13.91T KRW 14K%	-	South Korea
Sam Chun Dang Pharm. Co., Ltd. KRX: 000250	$6.77B 10.3T KRW 10K%	1958.1	South Korea
SK Biopharmaceuticals Co., Ltd. KRX: 326030	$5.24B 7.97T KRW 8K%	29.9	South Korea
ABL Bio Inc. KRX: 298380	$4.96B 7.55T KRW 7K%	-	South Korea
Yuhan Corp. KRX: 000100	$4.55B 6.92T KRW 7K%	35.9	South Korea
LigaChem Biosciences Inc. KRX: 141080	$4.44B 6.76T KRW 7K%	-	South Korea

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 1M%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 833K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 549K%	97.4	United States
Roche Holding AG SIX: RO	$321.52B 256.25B CHF 489K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$288.84B 215.59B GBP 439K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$274.65B 218.9B CHF 418K%	20.5	Switzerland

chevron_leftBack